BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11212150)

  • 41. Inhibition of adjuvant arthritis in rats by electroporation with interleukin-1 receptor antagonist.
    Sukedai M; Ariyoshi W; Okinaga T; Iwanaga K; Habu M; Yoshioka I; Tominaga K; Nishihara T
    J Interferon Cytokine Res; 2011 Nov; 31(11):839-46. PubMed ID: 21859345
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Suppressive effects of QFGJS, a preparation from an anti-arthritic herbal formula, on rat experimental adjuvant-induced arthritis.
    Cai X; Zhou H; Wong YF; Xie Y; Liu ZQ; Jiang ZH; Bian ZX; Xu HX; Liu L
    Biochem Biophys Res Commun; 2005 Nov; 337(2):586-94. PubMed ID: 16199007
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dual effect of nitric oxide donor on adjuvant arthritis.
    Gomaa AA; Elshenawy MM; Afifi NA; Mohammed EA; Thabit RH
    Int Immunopharmacol; 2009 Apr; 9(4):439-47. PubMed ID: 19193354
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of the development of collagen-induced arthritis in rhesus monkeys by a small molecular weight antagonist of CCR5.
    Vierboom MP; Zavodny PJ; Chou CC; Tagat JR; Pugliese-Sivo C; Strizki J; Steensma RW; McCombie SW; Celebi-Paul L; Remarque E; Jonker M; Narula SK; Hart B
    Arthritis Rheum; 2005 Feb; 52(2):627-36. PubMed ID: 15693002
    [TBL] [Abstract][Full Text] [Related]  

  • 45. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
    Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
    Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bone protective effect of simvastatin in experimental arthritis.
    Funk JL; Chen J; Downey KJ; Clark RA
    J Rheumatol; 2008 Jun; 35(6):1083-91. PubMed ID: 18464303
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dual inhibition of 5-lipoxygenase and cyclooxygenases 1 and 2 by ML3000 reduces joint destruction in adjuvant arthritis.
    Gay RE; Neidhart M; Pataky F; Tries S; Laufer S; Gay S
    J Rheumatol; 2001 Sep; 28(9):2060-5. PubMed ID: 11550975
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fcgamma receptors directly mediate cartilage, but not bone, destruction in murine antigen-induced arthritis: uncoupling of cartilage damage from bone erosion and joint inflammation.
    van Lent PL; Grevers L; Lubberts E; de Vries TJ; Nabbe KC; Verbeek S; Oppers B; Sloetjes A; Blom AB; van den Berg WB
    Arthritis Rheum; 2006 Dec; 54(12):3868-77. PubMed ID: 17133594
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of angiogenesis by interleukin-4 gene therapy in rat adjuvant-induced arthritis.
    Haas CS; Amin MA; Allen BB; Ruth JH; Haines GK; Woods JM; Koch AE
    Arthritis Rheum; 2006 Aug; 54(8):2402-14. PubMed ID: 16869003
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Scavenger receptor class A type I/II determines matrix metalloproteinase-mediated cartilage destruction and chondrocyte death in antigen-induced arthritis.
    van Lent PL; Hofkens W; Blom AB; Grevers L; Sloetjes A; Takahashi N; van Tits LJ; Vogl T; Roth J; de Winther MP; van den Berg WB
    Arthritis Rheum; 2009 Oct; 60(10):2954-65. PubMed ID: 19790077
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Experimental studies on the bone metabolism of male rats chronically exposed to cadmium intoxication using dual-energy X-ray absorptiometry.
    Yokota H; Tonami H
    Toxicol Ind Health; 2008 Apr; 24(3):161-70. PubMed ID: 18842694
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cartilage destruction in collagen induced arthritis assessed with a new biochemical marker for collagen type II C-telopeptide fragments.
    Ishikawa T; Nishigaki F; Christgau S; Noto T; Mo J; From N; Minoura K; Hirayama Y; Ohkubo Y; Mutoh S
    J Rheumatol; 2004 Jun; 31(6):1174-9. PubMed ID: 15170932
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cysteine protease activity is up-regulated in inflamed ankle joints of rats with adjuvant-induced arthritis and decreases with in vivo administration of a vinyl sulfone cysteine protease inhibitor.
    Biroc SL; Gay S; Hummel K; Magill C; Palmer JT; Spencer DR; Sa S; Klaus JL; Michel BA; Rasnick D; Gay RE
    Arthritis Rheum; 2001 Mar; 44(3):703-11. PubMed ID: 11263786
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A new class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis: Evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat models.
    Baragi VM; Becher G; Bendele AM; Biesinger R; Bluhm H; Boer J; Deng H; Dodd R; Essers M; Feuerstein T; Gallagher BM; Gege C; Hochgürtel M; Hofmann M; Jaworski A; Jin L; Kiely A; Korniski B; Kroth H; Nix D; Nolte B; Piecha D; Powers TS; Richter F; Schneider M; Steeneck C; Sucholeiki I; Taveras A; Timmermann A; Van Veldhuizen J; Weik J; Wu X; Xia B
    Arthritis Rheum; 2009 Jul; 60(7):2008-18. PubMed ID: 19565489
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CNI-1493, an inhibitor of proinflammatory cytokines, retards cartilage destruction in rats with collagen induced arthritis.
    Larsson E; Harris HE; Palmblad K; Månsson B; Saxne T; Klareskog L
    Ann Rheum Dis; 2005 Mar; 64(3):494-6. PubMed ID: 15708902
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Enzyme and combination therapy with cyclosporin A in the rat developing adjuvant arthritis.
    Rovenská E; Svík K; Stancíková M; Rovenský J
    Int J Tissue React; 1999; 21(4):105-11. PubMed ID: 10761540
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ro 32-3555, an orally active collagenase inhibitor, prevents cartilage breakdown in vitro and in vivo.
    Lewis EJ; Bishop J; Bottomley KM; Bradshaw D; Brewster M; Broadhurst MJ; Brown PA; Budd JM; Elliott L; Greenham AK; Johnson WH; Nixon JS; Rose F; Sutton B; Wilson K
    Br J Pharmacol; 1997 Jun; 121(3):540-6. PubMed ID: 9179398
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rapid inhibition of thyroxine-induced bone resorption in the rat by an orally active vitronectin receptor antagonist.
    Hoffman SJ; Vasko-Moser J; Miller WH; Lark MW; Gowen M; Stroup G
    J Pharmacol Exp Ther; 2002 Jul; 302(1):205-11. PubMed ID: 12065718
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Application of computer-based histomorphometry to the quantitative analysis of methylprednisolone-treated adjuvant arthritis in rats.
    Jee WS; Li XJ; Ke HZ; Li M; Smith RJ; Dunn CJ
    Bone Miner; 1993 Sep; 22(3):221-47. PubMed ID: 8268755
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A new spin on an old model: in vivo evaluation of disease progression by magnetic resonance imaging with respect to standard inflammatory parameters and histopathology in the adjuvant arthritic rat.
    Jacobson PB; Morgan SJ; Wilcox DM; Nguyen P; Ratajczak CA; Carlson RP; Harris RR; Nuss M
    Arthritis Rheum; 1999 Oct; 42(10):2060-73. PubMed ID: 10524677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.